Chapter 1: Introduction
1.1. Report Description
1.2. Key Benefits for Stakeholders
1.3. Key Market Segments
1.3.1. List of Key Players Profiled in the Report
1.4. Research Methodology
1.4.1. Secondary Research
1.4.2. Primary Research
1.4.3. Analyst Tools and Models
Chapter 2: Executive Summary
2.1. Key Findings of the Study
2.2. Cxo Perspective
Chapter 3: Market Landscape
3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top Investment Pockets
3.2.2. Top Winning Strategies
3.3. Porter’S Five Force Analysis
3.4. Top Player Positioning, 2019
3.5. Market Dynamics
3.5.1. Drivers
3.5.1.1. Increase in Air Pollution
3.5.1.2. Advantages Over Conventional Drug Delivery Devices
3.5.1.3. Increase in Prevalence of Copd and Asthma
3.5.1.4. Rise in Government Initiatives
3.5.2. Restraint
3.5.2.1. High Cost of Asthma and Copd Treatments
3.5.2.2. Lack of Access in Underdeveloped Countries
3.5.3. Opportunity
3.5.3.1. Growth Opportunities in Emerging Markets
3.5.4. Impact Analysis
3.6. Pricing Analysis of Aerosol Delivery Devices
3.7. Covid-19 Impact Analysis on Aerosol Delivery Devices Market
3.8. Top Manufacturers List by Region
3.9. Product Pipeline Analysis
3.10. License Terms Information
3.11. Qualitative Information on Mass Median Aerodynamic Diameter (Mmad)
3.12. Regulatory Information for U.S. Europe, Japan, and China: Aerosol Delivery Sevices
3.13. Innovations in Aerosol Delivery Devices Market
Chapter 4: Aerosol Delivery Devices Market, by Product
4.1. Overview
4.1.1. Market Size and Forecast
4.2. Dry Powder Inhalers (Dpis)
4.2.1. Key Market Trends, Growth Factors, and Opportunities
4.2.2. Market Size and Forecast, by Region
4.2.3. Market Analysis, by Country
4.2.4. Market Size and Forecast, by Type
4.2.5. Single Dose Inhalers
4.2.5.1. Market Size and Forecast
4.2.6. Multi Dose Inhalers
4.2.6.1. Market Size and Forecast
4.2.7. Market Size and Forecast, by Application
4.3. Metered Dose Inhalers (Mdis)
4.3.1. Key Market Trends, Growth Factors, and Opportunities
4.3.2. Market Size and Forecast
4.3.3. Market Analysis, by Country
4.3.4. Market Size and Forecast, by Type
4.3.5. Conventional Pressurized Inhalers
4.3.5.1. Market Size and Forecast
4.3.6. Soft Mist Inhalers
4.3.6.1. Market Size and Forecast
4.3.7. Market Size and Forecast, by Application
4.4. Nebulizers
4.4.1. Key Market Trends, Growth Factors, and Opportunities
4.4.2. Market Size and Forecast
4.4.3. Market Analysis, by Country
4.4.4. Market Size and Forecast, by Type
4.4.5. Jet Nebulizers
4.4.5.1. Market Size and Forecast
4.4.6. Ultrasonic Wave Nebulizers
4.4.6.1. Market Size and Forecast
4.4.7. Vibrating Mesh Nebulizers
4.4.7.1. Market Size and Forecast
4.4.8. Market Size and Forecast, by Application
Chapter 5: Aerosol Delivery Devices Market, by Application
5.1. Overview
5.1.1. Market Size and Forecast
5.2. Asthma
5.2.1. Market Size and Forecast, by Region
5.2.2. Market Analysis, by Country
5.3. Chronic Obstructive Pulmonary Disease (Copd)
5.3.1. Market Size and Forecast, by Region
5.3.2. Market Analysis, by Country
5.4. Cystic Fibrosis
5.4.1. Market Size and Forecast, by Region
5.4.2. Market Analysis, by Country
5.5. Non-Respiratory Diseases
5.5.1. Market Size and Forecast, by Region
5.5.2. Market Analysis, by Country
5.5.3. Market Size and Forecast, by Type
5.5.4. Diabetes
5.5.4.1. Market Size and Forecast
5.5.5. Analgesia
5.5.5.1. Market Size and Forecast
5.5.6. Parkinson's Disease
5.5.6.1. Market Size and Forecast
Chapter 6: Aerosol Delivery Devices Market, by Distribution Channel
6.1. Overview
6.1.1. Market Size and Forecast
6.2. Retail Pharmacies
6.2.1. Market Size and Forecast, by Region
6.2.2. Market Analysis, by Country
6.3. Hospital Pharmacies
6.3.1. Market Size and Forecast, by Region
6.3.2. Market Analysis, by Country
6.4. E-Commerce
6.4.1. Market Size and Forecast, by Region
6.4.2. Market Analysis, by Country
Chapter 7: Aerosol Delivery Devices Market, by Region
7.1. Overview
7.1.1. Market Size and Forecast
7.2. North America
7.2.1. Key Market Trends, Growth Factors, and Opportunities
7.2.2. Market Size and Forecast, by Country
7.2.2.1. U.S.
7.2.2.1.1. U.S. Aerosol Delivery Devices Market, by Product
7.2.2.1.2. U.S. Aerosol Delivery Devices Market, by Application
7.2.2.1.3. U.S. Aerosol Delivery Devices Market, by Distribution Channel
7.2.2.2. Canada
7.2.2.2.1. Canada Aerosol Delivery Devices Market, by Product
7.2.2.2.2. Canada Aerosol Delivery Devices Market, by Application
7.2.2.2.3. Canada Aerosol Delivery Devices Market, by Distribution Channel
7.2.2.3. Mexico
7.2.2.3.1. Mexico Aerosol Delivery Devices Market, by Product
7.2.2.3.2. Mexico Aerosol Delivery Devices Market, by Application
7.2.2.3.3. Mexico Aerosol Delivery Devices Market, by Distribution Channel
7.2.3. North America Market Size and Forecast, by Product
7.2.4. North America Market Size and Forecast, by Application
7.2.5. North America Market Size and Forecast, by Distribution Channel
7.3. Europe
7.3.1. Key Market Trends, Growth Factors, and Opportunities
7.3.2. Market Size and Forecast, by Country
7.3.2.1. Germany
7.3.2.1.1. Germany Aerosol Delivery Devices Market, by Product
7.3.2.1.2. Germany Aerosol Delivery Devices Market, by Application
7.3.2.1.3. Germany Aerosol Delivery Devices Market, by Distribution Channel
7.3.2.2. France
7.3.2.2.1. France Aerosol Delivery Devices Market, by Product
7.3.2.2.2. France Aerosol Delivery Devices Market, by Application
7.3.2.2.3. France Aerosol Delivery Devices Market, by Distribution Channel
7.3.2.3. UK
7.3.2.3.1. UK Aerosol Delivery Devices Market, by Product
7.3.2.3.2. UK Aerosol Delivery Devices Market, by Application
7.3.2.3.3. UK Aerosol Delivery Devices Market, by Distribution Channel
7.3.2.4. Italy
7.3.2.4.1. Italy Aerosol Delivery Devices Market, by Product
7.3.2.4.2. Italy Aerosol Delivery Devices Market, by Application
7.3.2.4.3. Italy Aerosol Delivery Devices Market, by Distribution Channel
7.3.2.5. Spain
7.3.2.5.1. Spain Aerosol Delivery Devices Market, by Product
7.3.2.5.2. Spain Aerosol Delivery Devices Market, by Application
7.3.2.5.3. Spain Aerosol Delivery Devices Market, by Distribution Channel
7.3.2.6. Rest of Europe
7.3.2.6.1. Rest of Europe Aerosol Delivery Devices Market, by Product
7.3.2.6.2. Rest of Europe Aerosol Delivery Devices Market, by Application
7.3.2.6.3. Rest of Europe Aerosol Delivery Devices Market, by Distribution Channel
7.3.3. Europe Market Size and Forecast, by Product
7.3.4. Europe Market Size and Forecast, by Application
7.3.5. Europe Market Size and Forecast, by Distribution Channel
7.4. Asia-Pacific
7.4.1. Key Market Trends, Growth Factors, and Opportunities
7.4.2. Market Size and Forecast, by Country
7.4.2.1. Japan
7.4.2.1.1. Japan Aerosol Delivery Devices Market, by Product
7.4.2.1.2. Japan Aerosol Delivery Devices Market, by Application
7.4.2.1.3. Japan Aerosol Delivery Devices Market, by Distribution Channel
7.4.2.2. China
7.4.2.2.1. China Aerosol Delivery Devices Market, by Product
7.4.2.2.2. China Aerosol Delivery Devices Market, by Application
7.4.2.2.3. China Aerosol Delivery Devices Market, by Distribution Channel
7.4.2.3. Australia
7.4.2.3.1. Australia Aerosol Delivery Devices Market, by Product
7.4.2.3.2. Australia Aerosol Delivery Devices Market, by Application
7.4.2.3.3. Australia Aerosol Delivery Devices Market, by Distribution Channel
7.4.2.4. India
7.4.2.4.1. India Aerosol Delivery Devices Market, by Product
7.4.2.4.2. India Aerosol Delivery Devices Market, by Application
7.4.2.4.3. India Aerosol Delivery Devices Market, by Distribution Channel
7.4.2.5. South Korea
7.4.2.5.1. South Korea Aerosol Delivery Devices Market, by Product
7.4.2.5.2. South Korea Aerosol Delivery Devices Market, by Application
7.4.2.5.3. South Korea Aerosol Delivery Devices Market, by Distribution Channel
7.4.2.6. Rest of Asia-Pacific
7.4.2.6.1. Rest of Asia-Pacific Aerosol Delivery Devices Market, by Product
7.4.2.6.2. Rest of Asia-Pacific Aerosol Delivery Devices Market, by Application
7.4.2.6.3. Rest of Asia-Pacific Aerosol Delivery Devices Market, by Distribution Channel
7.4.3. Asia-Pacific Market Size and Forecast, by Product
7.4.4. Asia-Pacific Market Size and Forecast, by Application
7.4.5. Asia-Pacific Market Size and Forecast, by Distribution Channel
7.5. LAMEA
7.5.1. Key Market Trends, Growth Factors, and Opportunities
7.5.2. Market Size and Forecast, by Country
7.5.2.1. Brazil
7.5.2.1.1. Brazil Aerosol Delivery Devices Market, by Product
7.5.2.1.2. Brazil Aerosol Delivery Devices Market, by Application
7.5.2.1.3. Brazil Aerosol Delivery Devices Market, by Distribution Channel
7.5.2.2. Saudi Arabia
7.5.2.2.1. Saudi Arabia Aerosol Delivery Devices Market, by Product
7.5.2.2.2. Saudi Arabia Aerosol Delivery Devices Market, by Application
7.5.2.2.3. Saudi Arabia Aerosol Delivery Devices Market, by Distribution Channel
7.5.2.3. South Africa
7.5.2.3.1. South Africa Aerosol Delivery Devices Market, by Product
7.5.2.3.2. South Africa Aerosol Delivery Devices Market, by Application
7.5.2.3.3. South Africa Aerosol Delivery Devices Market, by Distribution Channel
7.5.2.4. Rest of LAMEA
7.5.2.4.1. Rest of LAMEA Aerosol Delivery Devices Market, by Product
7.5.2.4.2. Rest of LAMEA Aerosol Delivery Devices Market, by Application
7.5.2.4.3. Rest of LAMEA Aerosol Delivery Devices Market, by Distribution Channel
7.5.3. LAMEA Market Size and Forecast, by Product
7.5.4. LAMEA Market Size and Forecast, by Application
7.5.5. LAMEA Market Size and Forecast, by Distribution Channel
Chapter 8: Company Profiles
8.1.3M Company
8.1.1. Company Overview
8.1.2. Company Snapshot
8.1.3. Operating Business Segments
8.1.4. Product Portfolio
8.1.5. Business Performance
8.2. Aerogen, Inc.
8.2.1. Company Overview
8.2.2. Company Snapshot
8.2.3. Operating Business Segments
8.2.4. Product Portfolio
8.3. GlaxoSmithKline plc (Gsk)
8.3.1. Company Overview
8.3.2. Company Snapshot
8.3.3. Operating Business Segments
8.3.4. Product Portfolio
8.3.5. Business Performance
8.4. Johnson & Johnson (Actelion Pharmaceuticals Ltd)
8.4.1. Company Overview
8.4.2. Company Snapshot
8.4.3. Operating Business Segments
8.4.4. Product Portfolio
8.4.5. Business Performance
8.4.6. Key Strategic Moves and Developments
8.5. Koninklijke Philips N. V.
8.5.1. Company Overview
8.5.2. Company Snapshot
8.5.3. Operating Business Segments
8.5.4. Product Portfolio
8.5.5. Business Performance
8.5.6. Key Strategic Moves and Developments
8.6. Merck & Co. Inc.
8.6.1. Company Overview
8.6.2. Company Snapshot
8.6.3. Operating Business Segments
8.6.4. Product Portfolio
8.6.5. Business Performance
8.7. Metall Zug Group (Clement Clarke International Ltd)
8.7.1. Company Overview
8.7.2. Company Snapshot
8.7.3. Operating Business Segments
8.7.4. Product Portfolio
8.7.5. Business Performance
8.8. Recipharm Ab (Bespak)
8.8.1. Company Overview
8.8.2. Company Snapshot
8.8.3. Operating Business Segments
8.8.4. Product Portfolio
8.8.5. Business Performance
8.8.6. Key Strategic Moves and Developments
8.9. Teva Pharmaceutical Industries Limited
8.9.1. Company Overview
8.9.2. Company Snapshot
8.9.3. Operating Business Segments
8.9.4. Product Portfolio
8.9.5. Business Performance
8.9.6. Key Strategic Moves and Developments
8.10. Vectura Group plc
8.10.1. Company Overview
8.10.2. Company Snapshot
8.10.3. Operating Business Segments
8.10.4. Product Portfolio
8.10.5. Business Performance
8.10.6. Key Strategic Moves and Developments
Chapter 9: Application Based Company Profiles
9.1. Gerresheimer AG
9.1.1. Company Overview
9.1.2. Company Snapshot
9.1.3. Operating Business Segments
9.1.4. Product Portfolio
9.1.5. Business Performance
9.2. Heitkamp & Thumann Kg (H&T Presspart)
9.2.1. Company Overview
9.2.2. Company Snapshot
9.2.3. Operating Business Segments
9.2.4. Product Portfolio
9.3. Iconovo Ab
9.3.1. Company Overview
9.3.2. Company Snapshot
9.3.3. Operating Business Segments
9.3.4. Product Portfolio
9.3.5. Key Strategic Moves and Developments
9.4. Merxin Ltd
9.4.1. Company Overview
9.4.2. Company Snapshot
9.4.3. Operating Business Segments
9.4.4. Product Portfolio
9.5. Nemera
9.5.1. Company Overview
9.5.2. Company Snapshot
9.5.3. Operating Business Segments
9.5.4. Product Portfolio